Ketamine Influences CLOCK:BMAL1 Function Leading to Altered Circadian Gene Expression
Open accessThe DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Major mood disorders have been linked to abnormalities in circadian rhythms, leading to disturbances in sleep, mood, temperature, and hormonal levels. We provide evidence that ketamine, a drug with rapid antidepressant effects, influences the function of the circadian molecular machinery. Ketamine modulates CLOCK:BMAL1-mediated transcriptional activation when these regulators are ectopically expressed in NG108-15 neuronal cells. Inhibition occurs in a dose-dependent manner and is attenuated after treatment with the GSK3β antagonist SB21673. We analyzed the effect of ketamine on circadian gene expression and observed a dose-dependent reduction in the amplitude of circadian transcription of the Bmal1, Per2, and Cry1 genes. Finally, chromatin-immunoprecipitation analyses revealed that ketamine altered the recruitment of the CLOCK:BMAL1 complex on circadian promoters in a time-dependent manner. Our results reveal a yet unsuspected molecular mode of action of ketamine and thereby may suggest possible pharmacological antidepressant strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clock genes are known to control circadian rhythms, and ketamine has been noted to induce their rapid expression,145”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [145]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
The selectivity of protein kinase inhibitors: a further update
Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., Mclauchlan, H., Klevernic, I., Arthur, J. S. C., Alessi, D. R., & Cohen, P. (2007) · Biochemical Journal · doi:10.1042/bj20070797 · Cited by 2,520
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084 · cited 1×
“This data suggests that the inhibitory effect of ketamine on circadian function involves GSK3b, a kinase that has been already implicated in the regulation of various circadian proteins [54–58] and which has been linked to the regulation of depressive disorders [59,60].”
BackgroundRole of the CLOCK Protein in the Mammalian Circadian Mechanism
Gekakis, N., Staknis, D., Nguyen, H. B., Davis, F. C., Wilsbacher, L. D., King, D. P., Takahashi, J. S., & Weitz, C. J. (1998) · Science · doi:10.1126/science.280.5369.1564 · Cited by 2,013
Nakahata, Y., Kaluzova, M., Grimaldi, B., Sahar, S., Hirayama, J., Chen, D., Guarente, L. P., & Sassone-Corsi, P. (2008) · Cell · doi:10.1016/j.cell.2008.07.002 · Cited by 1,427 · cited 1×
“ChIPs were performed on MEFs after serum shock synchronization and ketamine treatment, and analyzing the E-box in the Dbp UP region, previously validated to bind CLOCK:BMAL1 [61].”
MethodSelf-citationMaeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103 · cited 1×
“Ketamine, a non-competitive high affinity NMDA (N-methyl-D-aspartate) glutamate receptor antagonist, has rapid and robust antidepressant actions in animal models of depression when administered intravenously in low subanaesthetic doses [7].”
BackgroundCircadian Regulator CLOCK Is a Histone Acetyltransferase
Doi, M., Hirayama, J., & Sassone-Corsi, P. (2006) · Cell · doi:10.1016/j.cell.2006.03.033 · Cited by 887
Self-citationMania-like behavior induced by disruption of CLOCK
Roybal, K., Theobold, D., Graham, A., DiNieri, J. A., Russo, S. J., Krishnan, V., Chakravarty, S., Peevey, J., Oehrlein, N., Birnbaum, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609625104 · Cited by 803
The STAR*D project results: A comprehensive review of findings
Warden, D., Rush, A. J., Trivedi, M. H., Fava, M., & Wisniewski, S. R. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0061-3 · Cited by 727
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
aan het Rot, M., Collins, K. A., Murrough, J. W., Perez, A. M., Reich, D. L., Charney, D. S., & Mathew, S. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.038 · Cited by 690
Price, R. B., Nock, M. K., Charney, D. S., & Mathew, S. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.029 · Cited by 600 · cited 1×
“Approximately 35% of responders have sustained improvement up to 7 days after a single dose [10,11] or longer after repeated doses [12,13].”
BackgroundAntidepressants and the Risk of Suicidal Behaviors
Jick, H. (2004) · JAMA · doi:10.1001/jama.292.3.338 · Cited by 578
Nuclear Receptor Rev-erbα Is a Critical Lithium-Sensitive Component of the Circadian Clock
Yin, L., Wang, J., Klein, P. S., & Lazar, M. A. (2006) · Science · doi:10.1126/science.1121613 · Cited by 556
Bimodal regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 activity
Travnickova-Bendova, Z., Cermakian, N., Reppert, S. M., & Sassone-Corsi, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102075599 · Cited by 549
Self-citationCLOCK-mediated acetylation of BMAL1 controls circadian function
Hirayama, J., Sahar, S., Grimaldi, B., Tamaru, T., Takamatsu, K., Nakahata, Y., & Sassone-Corsi, P. (2007) · Nature · doi:10.1038/nature06394 · Cited by 525
Self-citationGlycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs
Gould, T. D., & Manji, H. K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300731 · Cited by 375
A Role for Glycogen Synthase Kinase-3β in the Mammalian Circadian Clock
Iitaka, C., Miyazaki, K., Akaike, T., & Ishida, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503526200 · Cited by 373
Circadian Clock Control by SUMOylation of BMAL1
Cardone, L., Hirayama, J., Giordano, F., Tamaru, T., Palvimo, J. J., & Sassone-Corsi, P. (2005) · Science · doi:10.1126/science.1110689 · Cited by 329
Self-citationGlutamate signalling in non-neuronal tissues
Skerry, T. M., & Genever, P. G. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01642-4 · Cited by 307
Regulation of BMAL1 Protein Stability and Circadian Function by GSK3β-Mediated Phosphorylation
Sahar, S., Zocchi, L., Kinoshita, C., Borrelli, E., & Sassone-Corsi, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008561 · Cited by 291
Self-citationBeurel, E., Song, L., & Jope, R. S. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.47 · Cited by 288
Bunney, W. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00145-1 · Cited by 268
Self-citationNowak, D. E., Tian, B., & Brasier, A. R. (2005) · BioTechniques · doi:10.2144/000112014 · Cited by 253
Mammalian circadian clock and metabolism – the epigenetic link
Bellet, M. M., & Sassone-Corsi, P. (2010) · Journal of Cell Science · doi:10.1242/jcs.051649 · Cited by 234
Self-citationGlutamatergic Modulators: The Future of Treating Mood Disorders?
Zarate, C., Machado-Vieira, R., Henter, I., Ibrahim, L., Diazgranados, N., & Salvadore, G. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673229.2010.511059 · Cited by 228
Multilevel regulation of the circadian clock
Cermakian, N., & Sassone-Corsi, P. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036078 · Cited by 226
Self-citationHarada, Y., Sakai, M., Kurabayashi, N., Hirota, T., & Fukada, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506225200 · Cited by 200
Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1
Yujnovsky, I., Hirayama, J., Doi, M., Borrelli, E., & Sassone-Corsi, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510691103 · Cited by 199
Self-citationDubrovsky, Y. V., Samsa, W. E., & Kondratov, R. V. (2010) · Aging · doi:10.18632/aging.100241 · Cited by 184
Diurnal variation of depressive symptoms
Wirz-Justice, A. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.3/awjustice · Cited by 169
Lithium lengthens the circadian period of individual suprachiasmatic nucleus neurons
Abe, M., Herzog, E. D., & Block, G. D. (2000) · NeuroReport · doi:10.1097/00001756-200009280-00042 · Cited by 169
Sumiyoshi, T., Anil, A. E., Jin, D., Jayathilake, K., Lee, M., & Meltzer, H. Y. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003900 · Cited by 169
Circadian rhythms and the pharmacology of affective illness
Duncan, W. C. (1996) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00092-7 · Cited by 167
Adrenal Cortical Activity in Depressive Illness
CARPENTER, W. T., & BUNNEY, W. E. (1971) · American Journal of Psychiatry · doi:10.1176/ajp.128.1.31 · Cited by 166
Self-citationAbe, H., Rusak, B., & Robertson, H. A. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90269-4 · Cited by 164
Colwell, C. S., & Menaker, M. (1992) · Journal of Biological Rhythms · doi:10.1177/074873049200700204 · Cited by 163
Circadian clock proteins control adaptation to novel environment and memory formation
A.Kondratova, A., V.Dubrovsky, Y., Antoch, M. P., & Kondratov, R. V. (2010) · Aging · doi:10.18632/aging.100142 · Cited by 153
The circadian clock gene period extends healthspan in aging Drosophila melanogaster
Krishnan, N., Kretzschmar, D., Rakshit, K., Chow, E., & Giebultowicz, J. M. (2009) · Aging · doi:10.18632/aging.100103 · Cited by 148
A serine cluster mediates BMAL1-dependent CLOCK phosphorylation and degradation
Spengler, M. L., Kuropatwinski, K. K., Schumer, M., & Antoch, M. (2009) · Cell Cycle · doi:10.4161/cc.8.24.10273 · Cited by 146
Sleep disturbances and depression: a challenge for antidepressants
Lam, R. W. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000195658.91524.61 · Cited by 143
Ketamine protects cultured neocortical neurons from hypoxic injury
Weiss, J., Goldberg, M. P., & Choi, D. W. (1986) · Brain Research · doi:10.1016/0006-8993(86)91447-2 · Cited by 142
Plasticity and specificity of the circadian epigenome
Masri, S., & Sassone-Corsi, P. (2010) · Nature Neuroscience · doi:10.1038/nn.2668 · Cited by 132
Self-citationEvidence for a novel glutamate-mediated signaling pathway in keratinocytes.
Genever, P., Maxfield, S. J., Kennovin, G. D., Maltman, J., Bowgen, C., Raxworthy, M., & Skerry, T. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00509.x · Cited by 129
Gelenberg, A. J., & Chesen, C. L. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1002 · Cited by 127
Depression, IV: STAR*D Treatment Trial for Depression
Rush, A. J., Trivedi, M. H., & D, M. F. M. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.237 · Cited by 126
Circadian abnormalities, molecular clock genes and chronobiological treatments in depression
Bunney, J. N., & Potkin, S. G. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn019 · Cited by 125
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
Nemeroff, C. B., MD, & PhD (2015) · Psychopharmacology Bulletin · doi:10.64719/pb.7083 · Cited by 109
Inhibitory Effects of Ketamine on Lipopolysaccharide-Induced Microglial Activation
Chang, Y., Lee, J.-J., Hsieh, C.-Y., Hsiao, G., Chou, D.-S., & Sheu, J.-R. (2009) · Mediators of Inflammation · doi:10.1155/2009/705379 · Cited by 108
PEET, N. M., GRABOWSKI, P. S., LAKETIć‐LJUBOJEVIć, I., & SKERRY, T. M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.15.2179 · Cited by 108
Cao, R., Li, A., Cho, H.-Y., Lee, B., & Obrietan, K. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5482-09.2010 · Cited by 103
Genever, P. G., Wilkinson, D. J. P., Patton, A. J., Peet, N. M., Hong, Y., Mathur, A., Erusalimsky, J. D., & Skerry, T. M. (1999) · Blood · doi:10.1182/blood.v93.9.2876 · Cited by 101
Photic regulation of the mTOR signaling pathway in the suprachiasmatic circadian clock
Cao, R., Lee, B., Cho, H.-Y., Saklayen, S. S., & Obrietan, K. H. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.03.005 · Cited by 97
Impaired light masking in dopamine D2 receptor–null mice
Doi, M., Yujnovsky, I., Hirayama, J., Malerba, M., Tirotta, E., Sassone‐Corsi, P., & Borrelli, E. (2006) · Nature Neuroscience · doi:10.1038/nn1711 · Cited by 84
Self-citationRapid-acting antidepressant strategies: mechanisms of action
Bunney, B. G., & Bunney, W. E. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000927 · Cited by 79 · cited 2×
“It is hypothesized that these treatments act by resetting abnormal circadian rhythms [8,22,23].”
BackgroundSelf-citationVisualization of mPer1 transcription in vitro
Asai, M., Yamaguchi, S., Isejima, H., Jonouchi, M., Moriya, T., Shibata, S., Kobayashi, M., & Okamura, H. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00445-6 · Cited by 73
Depressed Patients Have Higher Body Temperature: 5-HT Transporter Long Promoter Region Effects
Rausch, J. L., Johnson, M. E., Corley, K. M., Hobby, H. M., Shendarkar, N., Fei, Y., Ganapathy, V., & Leibach, F. H. (2003) · Neuropsychobiology · doi:10.1159/000070579 · Cited by 65
Chronopharmacological studies of ketamine in normal and NMDA Ε1 receptor knockout mice †
Sato, Y., Kobayashi, E., Hakamata, Y., Kobahashi, M., Wainai, T., Murayama, T., Mishina, M., & Seo, N. (2004) · British Journal of Anaesthesia · doi:10.1093/bja/aeh144 · Cited by 64
New Therapeutic Targets for Mood Disorders
Machado-Vieira, R., Salvadore, G., DiazGranados, N., Ibrahim, L., Latov, D., Wheeler-Castillo, C., Baumann, J., Henter, I. D., & Zarate, C. A. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.65 · Cited by 63
Vinogradova, I. A., Anisimov, V. N., Bukalev, A. V., Ilyukha, V. A., Хижкин, Е. А., Lotosh, T. A., Semenchenko, A. V., & Zabezhinski, M. A. (2010) · Aging · doi:10.18632/aging.100120 · Cited by 61
Ketamine inhibits nitric oxide synthase in lipopolysaccharide-treated rat alveolar macrophages
Li, C., Chou, T., Wong, C., Ho, S., Wu, C.-C., Yen, M., & Ding, Y. (1997) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03011971 · Cited by 57
Circadian expression of NMDA receptor mRNAs, ε3 and ζ1, in the suprachiasmatic nucleus of rat brain
Ishida, N., Matsui, M., Mitsui, Y., & Mishina, M. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90488-x · Cited by 57
CHASSARD, D., Duflo, F., Siqueira, M. D. Q., Allaouchiche, B., & Boselli, E. (2007) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e328136c55e · Cited by 40
Diurnal mood variation in outpatients with major depressive disorder
Morris, D. W., Trivedi, M. H., Fava, M., Wisniewski, S. R., Balasubramani, G. K., Khan, A. Y., Jain, S., & Rush, A. J. (2009) · Depression and Anxiety · doi:10.1002/da.20557 · Cited by 35
Mechanisms Involved in the Antiplatelet Activity of Ketamine in Human Platelets
Chang, Y., Chen, T.-L., Wu, G., Hsiao, G., Shen, M., Lin, K., Chou, D., Lin, C., & Sheu, J. (2004) · Journal of Biomedical Science · doi:10.1007/bf02254361 · Cited by 34
Shang, L. H., Luo, Z. Q., Deng, X., Wang, M. J., Huang, F., Feng, D.-Y., & Yue, S. (2010) · Nitric Oxide · doi:10.1016/j.niox.2010.09.004 · Cited by 28
Chambille, I. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01460-2 · Cited by 25
Paul, K. N., Fukuhara, C., Tosini, G., & Albers, H. E. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00098-8 · Cited by 24
Paul, K. N., Fukuhara, C., Karom, M. C., Tosini, G., & Albers, H. E. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.05.017 · Cited by 23
Mechanisms Underlying Glutamate-induced Swelling of Astrocytes in Primary Culture
Chan, P. H., & Chu, L. (1990) · Springer eBooks · doi:10.1007/978-3-7091-9115-6_3 · Cited by 22
Manipulation of Mammalian Cell Lines for Circadian Studies
Tamanini, F. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-257-1_36 · Cited by 14
Circadian clock-coordinated hepatic lipid metabolism: only transcriptional regulation?
Gachon, F., & Bonnefont, X. (2010) · Aging · doi:10.18632/aging.100123 · Cited by 10
Aging brains and waning clocks on the process of habituation
Eckel‐Mahan, K. L., & Sassone‐Corsi, P. (2010) · Aging · doi:10.18632/aging.100154 · Cited by 2
Self-citationManipulation of Mammalian Cell Lines for Circadian Studies
Tamanini, F. (2007) · Humana Press eBooks · doi:10.1385/1-59745-257-2:443 · Cited by 1
Cited by
The circadian clock and pathology of the ageing brain
Kondratova, A. A., & Kondratov, R. V. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3208 · Cited by 482
Matveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M.-A., Baker, G. B., & Dursun, S. M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916657 · Cited by 209
Vadnie, C. A., & McClung, C. A. (2017) · Neural Plasticity · doi:10.1155/2017/1504507 · Cited by 199
“Ketamine was found to dampen circadian gene expression amplitude in mouse embryonic fibroblasts [377].”
Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder
Bunney, B. G., Li, J. Z., Walsh, D. M., Stein, R., Vawter, M. P., Cartagena, P., Barchas, J. D., Schatzberg, A. F., Myers, R. M., Watson, S. J., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.138 · Cited by 180
Self-citationBunney, B. G., & Bunney, W. E. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.07.020 · Cited by 181
Self-citation
Metadata
- Authors
- Bellet, M. M., Vawter, M. P., Bunney, B. G., Bunney, W. E., & Sassone-Corsi, P.
- Affiliations
- University of California, Irvine (US)
- Corresponding author
- Bunney, William E.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-08-24
- Volume
- 6
- Issue
- 8
- Pages
- e23982
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3161090
- OpenAlex
- W2171839813
- Cited by
- 70
- References
- 76
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 8 · 2022: 6 · 2021: 9 · 2020: 4 · 2019: 4 · 2018: 6 · 2017: 6 · 2016: 3 · 2015: 6 · 2014: 3 · 2013: 2 · 2012: 3
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Della Martin Foundation
- National Institutes of Health (AG033888)
- National Institute on Aging (R21AG033888)
- National Institute of Mental Health (R01MH085801)
- National Institute of General Medical Sciences (R01GM081634)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Keywords
- ketamine, circadian clock, Clock/BMAL1, circadian gene expression, GSK3β, antidepressant mechanism, mood disorders, circadian rhythm, Per2, CRY1, Bmal1, transcriptional repression, chromatin recruitment, NG108-15 cells
- MeSH terms
- Animals, Gene Expression Regulation, Ketamine, Poly(ADP-ribose) Polymerases, Species Specificity, Excitatory Amino Acid Antagonists, Mice, Circadian Rhythm Signaling Peptides and Proteins, CLOCK Proteins, Cryptochromes, Period Circadian Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.